Cognizant Technology Solutions Corporation

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +50

Is Cognizant Technology Solutions Corporation (CTSH) Among the Most Undervalued Tech Stocks to Buy?

AI-generated analysis

πŸ“ˆ Cognizant Technology Solutions Corporation (CTSH) is highlighted as one of the most undervalued stocks in the tech sector.

πŸ€– On May 29, CTSH announced it is opening its TriZetto Unify platform to AI agents for healthcare workflows.

πŸ₯ The new AI agent integration targets delays in prior authorization and involves physicians in clinical decisions.

πŸ—£οΈ Prasad Sankaran, President of Cognizant AI Products and Platforms, stated that AI agents are joining human users in enterprise workflows.

βš–οΈ He emphasized that these systems must be policy-governed and auditable, treating agents as first-tier consumers.

πŸ”Œ The Electronic Prior Authorization is the first live use case, exposing services through headless APIs for automated execution.

πŸ’° Surya Gummadi, President of Cognizant Americas, noted that prior authorization creates real pressure to cut administrative costs.

⏱️ He added that AI agents can handle non-clinical work while preserving physician oversight.

πŸ“Š Citing American Medical Association data, CTSH reported that 95% of physicians experience delays tied to prior authorization.

⏳ Staff currently spend approximately 13 hours weekly on prior authorization requests according to the company's data.

πŸ‘₯ The TriZetto platforms support over 200 million members and process more than $500 billion annually.

πŸ’Ό CTSH provides IT, consulting, and business process outsourcing services across Healthcare Sciences, Financial Services, Products and Resources, and Communications segments.

⚠️ The article notes that while CTSH has investment potential, the authors believe other AI stocks may offer higher returns in a shorter time frame.

πŸ” Readers are directed to check out a separate report about a different AI stock with claimed 10,000% upside potential.

πŸ“° Additional unrelated headlines include Klaviyo climbing 15.9%, Arm Holdings hitting an all-time high, and various other tech stock recommendations.

Bullish Signals
  • Cognizant Technology Solutions Corporation (CTSH) is identified as one of the most undervalued stocks in the market.
  • On May 29, CTSH announced it is opening its TriZetto Unify platform to AI agents to address delays in prior authorization and involve physicians in clinical decisions.
  • The company's Electronic Prior Authorization use case exposes services through headless APIs that enable automated workflows and agent-based execution.
  • CTSH's TriZetto platforms support over 200 million members and process more than $500 billion annually, highlighting significant market scale.
  • According to American Medical Association data cited by the company, 95% of physicians report delays tied to prior authorization, presenting a clear opportunity for CTSH's AI solutions.
Risk Factors
  • The article explicitly states that while acknowledging the risk and potential of CTSH, the author's conviction lies in other AI stocks holding greater promise for delivering higher returns within a shorter time frame.
  • The text suggests that if an investor is looking for an AI stock more promising than CTSH with significant upside potential (10,000%), they should check out another report, implying CTSH may not offer the same growth prospects.
Full Analysis
Cognizant Technology Solutions Corporation (CTSH) announced on May 29 that it is opening its TriZetto Unify platform to AI agents, specifically targeting delays in prior authorization and involving physicians in clinical decisions. Prasad Sankaran, President of Cognizant AI Products and Platforms, stated that these AI agents are joining human users in enterprise workflows and require systems that are policy-governed and auditable, with future solutions treating agents as first-tier consumers. The company highlighted Electronic Prior Authorization as its first live use case, which exposes services through headless APIs to allow automated workflows and agent-based execution. Surya Gummadi, President of Cognizant Americas, noted that prior authorization shows real pressure to cut administrative costs, adding that the AI agents can handle non-clinical work while preserving physician oversight. Cognizant cited American Medical Association data indicating that 95% of physicians report delays tied to prior authorization and that staff spend 13 hours weekly on requests. The TriZetto platforms support over 200 million members and process more than $500 billion annually. Cognizant provides information technology, consulting, and business process outsourcing services through segments including Healthcare Sciences, Financial Services, Products and Resources, and Communications, Media, and Technology.